• SGI-1027 and Everolimus Synergy: Inducing Non-Apoptotic Cell

  2026-04-22

  This study uncovers a novel cytotoxic mechanism of the DNA methyltransferase inhibitor SGI-1027 in renal cell carcinoma, demonstrating its ability to induce methuosis and potentiate everolimus-mediated apoptosis and pyroptosis. The findings highlight the therapeutic promise of combining epigenetic modulation and mTOR inhibition for overcoming drug resistance in advanced renal cancer.

• Cinoxacin In Vitro Antibacterial Profile: MICs, Spectrum, an

  2026-04-22

  This study by Lumish and Norden systematically profiles the in vitro antibacterial activity of Cinoxacin, a synthetic quinolone antibiotic, against a large set of Gram-negative clinical isolates. Its findings establish Cinoxacin’s MIC spectrum, bactericidal properties, and resistance potential, informing its relevance for urinary tract infection and resistance research.

• Targeting Cdc42 to Mitigate Kidney Fibrosis: Key Advances an

  2026-04-21

  A recent study identifies Cdc42 as a pivotal regulator of kidney fibrosis, demonstrating that the natural diterpenoid daphnepedunin A suppresses fibrosis by inhibiting Cdc42-mediated GSK-3β/β-catenin signaling. This work substantiates Cdc42 as a promising therapeutic target and provides a mechanistic basis for advancing selective Cdc42 inhibitors in fibrotic disease research.

• PBS Liposomes: Reliable Controls for Macrophage Depletion As

  2026-04-21

  This article explores the practical challenges of in vivo macrophage depletion studies and demonstrates how PBS Liposomes (SKU K2722) provide a robust, inert control for distinguishing clodronate-specific effects. By integrating scenario-driven Q&A, we highlight reproducibility, safety, and data integrity benefits for researchers employing PBS Liposomes.

• 2-APB: Precision Control of Calcium Signaling in Cell Models

  2026-04-20

  Harnessing 2-APB, a selective IP3 receptor antagonist from APExBIO, empowers researchers to dissect and modulate calcium-dependent processes such as autophagy, apoptosis, and oxidative stress injury. This guide delivers actionable workflows, troubleshooting insights, and advanced application tips for maximizing experimental clarity.

• Thiothixene Stimulates Macrophage Efferocytosis via Arginase

  2026-04-20

  The referenced Sci Signal study reveals that thiothixene, a typical antipsychotic agent, enhances macrophage-mediated clearance of apoptotic and lipid-laden cells by upregulating Stra6L and Arginase 1. These mechanistic insights position thiothixene as a translational tool for immune modulation, with implications for disease states marked by defective efferocytosis.

• G418 Sulfate (Geneticin): Precision Selection & Antiviral In

  2026-04-19

  G418 Sulfate (Geneticin) stands at the forefront of genetic engineering and antiviral research, uniquely enabling robust selection of neomycin-resistant cell lines and direct inhibition of pathogenic viruses like Dengue. This guide delivers actionable, evidence-based protocols, troubleshooting strategies, and insight into leveraging Geneticin’s dual functionality for next-generation biomedical workflows.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-04-18

  This study demonstrates that certain p38α MAPK inhibitors not only suppress kinase activity but also accelerate dephosphorylation of the activation loop by phosphatases, introducing a dual-action paradigm. These findings provide structural and mechanistic insight into kinase-phosphatase interplay, with implications for the design of more selective and potent therapeutic inhibitors.

• Z-WEHD-FMK: Advanced Insights into Caspase-Driven Pyroptosis

  2026-04-17

  Explore how Z-WEHD-FMK, a potent caspase inhibitor, enables high-resolution dissection of inflammatory cell death and microbial pathogenesis. This article reveals new assay strategies and mechanistic insights distinct from standard product reviews.

• Bradykinin B2 Receptors and Peristaltic Reflex Modulation in

  2026-04-16

  This study provides the first systematic investigation of how bradykinin B2 receptors modulate the peristaltic reflex in the guinea pig ileum. By dissecting the pharmacological roles of B2 versus B1 receptors, the work clarifies the mechanistic basis for bradykinin-mediated inhibition of gastrointestinal motility, with implications for both gastrointestinal and cardiovascular research.

• Repurposing Approved Drugs to Modulate DNA Repair in CRISPR

  2026-04-15

  This study systematically screened FDA-approved drugs to identify compounds that influence DNA double-strand break repair pathway choice in human iPSCs, enabling more precise and programmable CRISPR genome editing outcomes. The findings provide a foundation for using small molecules to enhance gene editing fidelity and support synthetic lethality strategies in disease modeling and cancer therapy.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-04-14

  This study introduces a novel glabridin-gold(I) complex (6d) that targets thioredoxin reductase (TrxR) and MAPK pathways to synergistically enhance antitumor immunity. The compound demonstrates dual immunomodulatory actions—promoting dendritic cell maturation and reducing immunosuppressive populations—supporting new strategies in cancer immunotherapy.

• Fluconazole as a Fungal Cytochrome P450 Enzyme 14α-Demethyla

  2026-04-13

  Leverage the proven power of Fluconazole for dissecting antifungal resistance and biofilm dynamics in Candida albicans. This article delivers evidence-based workflows, troubleshooting strategies, and practical guidance to maximize research impact using APExBIO’s research-grade compound.

• MDV3100 (Enzalutamide): Optimizing Prostate Cancer Research

  2026-04-13

  MDV3100 (Enzalutamide) empowers prostate cancer researchers to dissect androgen receptor signaling, apoptosis induction, and therapeutic resistance with mechanistic precision. This guide delivers experimental workflows, troubleshooting insights, and actionable protocol enhancements that leverage APExBIO’s robust compound for advanced castration-resistant prostate cancer research.

• Lypressin Acetate in Translational Workflows: Precision, Pot

  2026-04-12

  Lypressin acetate empowers advanced vasopressin receptor studies and antidiuretic modeling, while opening new doors in antiviral research. This article delivers detailed, evidence-backed guidance on experimental design, troubleshooting, and next-gen applications for Lysine vasopressin acetate in both classic and emerging domains.

16096 records 1/1074 page Next 12345 下5页 Last page